The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation

KARASU G. T., YESILIPEK M. A., KARAUZUM S. B., Uygun V., Manguoğlu E., Kupesiz A., ...More

PEDIATRIC BLOOD & CANCER, vol.58, no.3, pp.453-458, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 58 Issue: 3
  • Publication Date: 2012
  • Doi Number: 10.1002/pbc.23350
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.453-458
  • Keywords: donor lymphocyte infusion, graft rejection thalassemia, hemoglobinopathies, mixed chimerism, stem cell transplantation, BONE-MARROW-TRANSPLANTATION, MIXED CHIMERISM, REGIMENS
  • Akdeniz University Affiliated: Yes


Background The aim was to evaluate the feasibility of donor lymphocyte infusion (DLI) in transplanted patients with thalassemia who were at imminent risk of graft rejection (GR).